𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Octreotide for advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials

✍ Scribed by Tian-Kang Guo; Xiang-Yong Hao; Bin Ma; Ke-Hu Yang; Yi-Ping Li; Hong-Ling Li; Yuan-Hui Gu; Hui Cai; Ya-Li Liu; Yuan Li; Wei-Peng Zhan

Publisher
Springer-Verlag
Year
2009
Tongue
English
Weight
326 KB
Volume
135
Category
Article
ISSN
1432-1335

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Randomized controlled trial of interfero
Randomized controlled trial of interferon treatment for advanced hepatocellular carcinoma
✍ Josep M. Llovet; Margarita Sala; LluΓ­s Castells; Yanette Suarez; Ramon Vilana; L πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 80 KB πŸ‘ 2 views

The aim of this randomized controlled trial was to assess the efficacy of interferon alfa-2b (IFN) for the treatment of advanced hepatocellular carcinoma (HCC). Fifty-eight patients with HCC who were not suitable for resection, transplantation, ethanol injection, or arterial embolization were strati

A meta-analysis of survival rates of unt
A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
✍ Giuseppe Cabibbo; Marco Enea; Massimo Attanasio; Jordi Bruix; Antonio CraxΓ¬; Cal πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 406 KB

Knowing the spontaneous outcome of hepatocellular carcinoma (HCC) is important for designing randomized controlled trials (RCTs) of new therapeutic approaches; however, survival of patients in the absence of treatment is highly variable, and prognostic factors influencing outcomes are incompletely d